Primary Record
Lactosylceramide
- In stock
- 6,189 g
- Purity
- 98.6 %
- CAS
- 105087-85-2
Compound Identifiers & Properties
- CAS
- 105087-85-2
- PubChem CID
- 53481001
- SMILES
- CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O)[C@@H](/C=C/CCCCCCCCCCCCC)O
- Canonical SMILES
- CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCCCCCCCCCCCCCC
Names & Synonyms
- Lactosylceramide
- LacCer
- Cytolipin H
- CDw17 antigen
- C24 lactosyl ceramide
- lactosyl-n-acylsphingosine
- LacCer(d18:1/24:0)
- SCHEMBL30654300
- CHEBI:84764
- N-Lignoceryl sphingosyl lactoside
- Gal-beta1->4Glc-beta1->1'Cer
- Lactosyl ceramide (d18:1/24:0)
- N-(tetracosanoyl)-1-b-lactosyl-sphing-4-enine
- D-Galactosyl-1,4-beta-D-glucosylceramide
- c24 lactosyl(beta) ceramide (d18:1/24:0)
- 105087-85-2
- N-(hexadecanoyl)-1-b-lactosyl-sphing-4-enine
- beta-D-Galactosyl-1,4-beta-D-glucosylceramide
- delta-Galactosyl-1,4-beta-delta-glucosylceramide
- N-(hexadecanoyl)-1-beta-lactosyl-sphing-4-enine
- beta-delta-Galactosyl-1,4-beta-delta-glucosramide
- N-(tetracosanoyl)-1-beta-lactosyl-sphing-4-enine
- Beta-delta-Galactosyl-1,4-beta-delta-Glucosylceramide
- Q27158050
- D-lactosyl-beta-1,1' N-lignoceroyl-D-erythro-sphingosine
- 1-O-(4-O-b-D-galactopyranosyl-b-D-glucopyranosyl)-Ceramide
- 1-O-(4-O-beta-D-Galactopyranosyl-beta-glucopyranosyl)ceramide
- beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-N-tetracosanoylsphingosine
- 1-O-(4-O-beta-delta-Galactopyranosyl-beta-glucopyranosyl)ceramide
- 1-O-(4-O-beta-delta-galactopyranosyl-beta-delta-glucopyranosyl)-Ceramide
- 1ylce-O-(4-O-beta-delta-Galactopyranosyl-beta-glucopyranosyl)ceramide
- O,O-diethyl N-[2-(dipropylamino)-2-oxoethyl]-N-ethylphosphoramidothioate
- CDH
- N-((2S,3R,E)-1-(((2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxyoctadec-4-en-2-yl)tetracosanamide
- N-[(2S,3R,4E)-1-{[4-O-(beta-D-galactopyranosyl)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]tetracosanamide
- N-[(E,2S,3R)-1-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]tetracosanamide
- N-[1-{[3.4-dihydroxy-6-(hydroxymethyl)-5-{[3.4.5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]tetracosanamide
- Tetracosanamide, N-[(1S,2R,3E)-1-[[(4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-
- Tetracosanamide,N-[(1S,2R,3E)-1-[[(4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-